首页> 外国专利> AGENT FOR ALLEVIATION OF FUNCTIONAL DISORDER AFTER CARDIOPULMONARY RESUSCITATION

AGENT FOR ALLEVIATION OF FUNCTIONAL DISORDER AFTER CARDIOPULMONARY RESUSCITATION

机译:心肺复苏后缓解功能障碍的代理商

摘要

A medicine useful for the alleviation of functional disorders after cardiopulmonary resuscitation. The agent for alleviation of functional disorders after cardiopulmonary resuscitation contains as an active ingredient a pyrazolone derivative represented by the following formula (I): (I) (wherein R1 represents hydrogen, aryl, etc. and R2 represents hydrogen, aryloxy, etc. or R1 and R2 in cooperation represent C3-5 hydroxyalkyl; and R3 represents hydrogen, C1-5 alkyl, phenyl, etc.), a physiologically acceptable salt of the derivative, or a hydrate or solvate of either.
机译:一种用于减轻心肺复苏后功能性疾病的药物。用于心肺复苏后的功能障碍的缓解剂包含由下式(I)表示的吡唑啉酮衍生物作为活性成分:(I)(其中R1代表氢,芳基等,R2代表氢,芳氧基等)或R 1和R 2共同代表C 3-5羟烷基; R 3代表氢,C 1-5烷基,苯基等),衍生物的生理学上可接受的盐,或两者的水合物或溶剂化物。

著录项

  • 公开/公告号WO2004037249A1

    专利类型

  • 公开/公告日2004-05-06

    原文格式PDF

  • 申请/专利权人 MITSUBISHI PHARMA CORPORATION;AKIYAMA KATSUNORI;

    申请/专利号WO2003JP13769

  • 发明设计人 AKIYAMA KATSUNORI;

    申请日2003-10-28

  • 分类号A61K31/4152;A61P11/00;A61P43/00;

  • 国家 WO

  • 入库时间 2022-08-21 22:56:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号